Isorhamnetin ameliorates inflammatory responses and articular cartilage damage in the rats of monosodium iodoacetate-induced osteoarthritis

References

• Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365:965–973.
   PubMed Web of Science ®Google Scholar
• Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625–635.
   PubMed Web of Science ®Google Scholar
• Bricca A, Struglics A, Larsson S, et al. Impact of exercise therapy on molecular biomarkers related to cartilage and inflammation in people at risk of, or with established, knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken). 2018. DOI:10.1002/acr.23786
   PubMedGoogle Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388.
   PubMed Web of Science ®Google Scholar
• Del Grossi Moura M, Lopes LC, Biavatti MW, et al. Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: a systematic review and meta-analysis. Phytother Res. 2017;31:1676–1685.
   PubMed Web of Science ®Google Scholar
• Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases. Molecules. 2017;22:1915.
   PubMed Web of Science ®Google Scholar
• Rohdewald PJ. Review on sustained relief of osteoarthritis symptoms with a proprietary extract from pine bark, pycnogenol. J Med Food. 2018;21:1–4.
   PubMed Web of Science ®Google Scholar
• Qi F, Sun JH, Yan JQ, et al. Anti-inflammatory effects of isorhamnetin on LPS-stimulated human gingival fibroblasts by activating Nrf2 signaling pathway. Microb Pathog. 2018;120:37–41.
   PubMed Web of Science ®Google Scholar
• Manu KA, Shanmugam MK, Ramachandran L, et al. Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-kappaB signaling cascade in gastric cancer. Cancer Lett. 2015;363:28–36.
   PubMed Web of Science ®Google Scholar
• Chen TL, Zhu GL, Wang JA, et al. Protective effects of isorhamnetin on apoptosis and inflammation in TNF-alpha-induced HUVECs injury. Int J Clin Exp Pathol. 2015;8:2311–2320.
   PubMed Web of Science ®Google Scholar
• Dong GZ, Lee JH, Ki SH, et al. AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction. Eur J Pharmacol. 2014;740:634–640.
   PubMed Web of Science ®Google Scholar
• Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis - chondrocytes in focus. Cell Signal. 2019;53:212–223.
   PubMed Web of Science ®Google Scholar
• Mankin HJ, Dorfman H, Lippiello L, et al. ZarinsBiochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53:523–537.
   PubMed Web of Science ®Google Scholar
• Sarkar D, Saha P, Gamre S, et al. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated bysuppression of iNOS and COX-2 via the NF-kappaB pathway. Int Immunopharmacol. 2008;8:1264–1271.
   PubMed Web of Science ®Google Scholar
• Goode AP, Marshall SW, Kraus VB, et al. Association between serum and urine biomarkers and lumbar spine individual radiographic features: The Johnston County Osteoarthritis Project. Osteoarthritis Cartilage. 2012;20:1286–1293.
   PubMed Web of Science ®Google Scholar
• Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG, et al. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Res Ther. 2016;18:81.
   PubMed Web of Science ®Google Scholar
• Honsawek S, Tanavalee A, Sakdinakiattikoon M, et al. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Biochem. 2009;42:808–812.
   Web of Science ®Google Scholar
• MacGregor AJ, Li Q, Spector TD, et al. The genetic influence on radiographic osteoarthritis is site specific at the hand, hip and knee. Rheumatology (Oxford). 2008;48:277–280.
   Web of Science ®Google Scholar
• Addimanda O, Mancarella L, Dolzani P, et al. Clinical associations in patients with hand osteoarthritis. Scand J Rheumatol. 2012;41:310–313.
   PubMed Web of Science ®Google Scholar
• Michl GL, Katz JN, Losina E. Risk and risk perception of knee osteoarthritis in the US: a population-based study. Osteoarthritis Cartilage. 2016;24:593–596.
   PubMed Web of Science ®Google Scholar
• Meliconi R, Pulsatelli L. Are mechanisms of inflammation joint-specific in osteoarthritis? Rheumatology (Oxford). 2018;58:743–745
   Web of Science ®Google Scholar
• Sae-Jung T, Sengprasert P, Apinun J, et al. Functional and T cell receptor repertoire analyses of peripheral blood and infrapatellar fat pad T cells in knee osteoarthritis. J Rheumatol. 2018;46:309–317
   PubMed Web of Science ®Google Scholar
• Seo K, Yang JH, Kim SC, et al. The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: a potential role of HO-1. Inflammation. 2014;37:712–722.
   PubMed Web of Science ®Google Scholar
• Li H, Xie S, Qi Y, et al. TNF-α increases the expression of inflammatory factors in synovial fibroblasts by inhibiting thePI3K/AKT pathway in a rat model of monosodium iodoacetate-induced osteoarthritis. Exp Ther Med. 2018;16:4737–4744.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao SG, Zhang FJ, et al. Effects of osteopontin on the expression of IL-6 and IL-8 inflammatory factors in human knee osteoarthritis chondrocytes. Eur Rev Med Pharmacol Sci. 2014;18:3580–3586.
   PubMed Web of Science ®Google Scholar
• Hamalainen M, Nieminen R, Vuorela P, et al. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007;2007:45673.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhong W. Isorhamnetin attenuates collagen-induced arthritis via modulating cytokines and oxidative stress in mice. Int J Clin Exp Med. 2015;8:16536–16542.
   PubMed Web of Science ®Google Scholar
• Li J, Wu R, Qin X, et al. Isorhamnetin inhibits IL1betainduced expression of inflammatory mediators in human chondrocytes. Mol Med Rep. 2017;16:4253–4258.
   PubMed Web of Science ®Google Scholar
• Shi H, He J, Li X, et al. Isorhamnetin, the active constituent of a Chinese herb Hippophae rhamnoides L, is a potent suppressor of dendritic-cell maturation and trafficking. Int Immunopharmacol. 2018;55:216–222.
   PubMed Web of Science ®Google Scholar
• Ahn H, Lee GS. Isorhamnetin and hyperoside derived from water dropwort inhibits inflammasome activation. Phytomedicine. 2017;24:77–86.
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Song JQ, Pan SY, et al. Treatment with isorhamnetin protects the brain against ischemic injury in mice. Neurochem Res. 2016;41:1939–1948.
   PubMed Web of Science ®Google Scholar
• Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 2001;29:209–215.
   PubMed Web of Science ®Google Scholar
• Vilím V, Olejárová M, Machácek S, et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage. 2002;10:707–713.
   PubMed Web of Science ®Google Scholar
• Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, et al. The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of humancartilage collagen degradation. Osteoarthritis Cartilage. 2008;16:1183–1191.
   PubMed Web of Science ®Google Scholar
• Freeston JE, Garnero P, Wakefield R, et al. Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis. Ann Rheum Dis. 2011;70:331–333.
   PubMed Web of Science ®Google Scholar
• Jansen NW, Roosendaal G, Lundin B, et al. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis Rheum. 2009;60:290–298.
   PubMed Web of Science ®Google Scholar
• Denhardt DT. Osteopontin expression and function role in bone remodeling. J Cell Biochem Supplements. 1998;30:92–102.
   PubMedGoogle Scholar
• Roy K, Kanwar RK, Kanwar JR. Molecular targets in arthritis and recent trends in nanotherapy. Int J Nanomedicine. 2015;10:5407–5420.
   PubMed Web of Science ®Google Scholar
• El Deeb S, Abdelnaby R, Khachab A, et al. Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis. Hip Int. 2016;26:397–403.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang W, Zhang F, et al. NEAT1/miR-181c regulates osteopontin (OPN)-mediated synoviocyte proliferation in osteoarthritis. J Cell Biochem. 2017;118:3775–3784.
   PubMed Web of Science ®Google Scholar
• Gao SG, Li KH, Zeng KB, et al. Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis Cartilage. 2010;18:82–87.
   PubMed Web of Science ®Google Scholar